FEMICURE 20 MG 30 CAPS

Femicure has an inhibitory effect on prolactin release through a dopaminergic principle of action mediated by D2 receptors (binding inhibition). Lowering the prolactin level cancels the disturbed secretion of gonadotrophins and normalizes the physiological estrogen/progesterone ratio which in turn abolishes the proliferative effect of prolactin on the mammary gland. Additional action in relieving pre-menstrual syndrome may be mediated by opioid receptors binding inhibition. Indications: -Pre-menstrual syndrome. -Mastalgia due to hormonal disturbances as hyper-prolactinemia. -Menstrual disorders as menorrhagia metrorrhagia polymenorrhea and oligomenorrhea. Dose: 1 caps in the morning for at least 3 monthes.